(lp0
S"Stock Update : Galena Biopharma Inc Announces 4Q and Year End ... Smarter Analyst - Mar 15, 2017 Galena Biopharma Inc  reported its financial results for the quarter and year ended December 31, 2016. I am honored to be selected by the Board of Directors to lead Galena as we explore the best possible outcome for the company and its&nbsp;...Zacks Investment Research Upgrades Galena Biopharma Inc  to Strong-Buy - The Cerbat GemToday's Research Reports on Stocks to Watch: Geron and Galena Biopharma - Yahoo Finance"
p1
aS'Traders Secrets on Callaway Golf Company , Galena Biopharma, Inc.  StockNewsJournal - 15 hours ago Galena Biopharma, Inc. , at its latest closing price of $0.59, it has a price-to-book ratio of 0.33, compared to an industry average at 4.12.'
p2
aS'Galena Biopharma Inc  Hires Canaccord Genuity to Advise on Strategic ... Smarter Analyst - Mar 9, 2017 Galena Biopharma Inc  announced it has engaged Canaccord Genuity, Inc. as its financial advisor to assist in the previously announced strategic alternative review process.Most Active Stock: Galena Biopharma, Inc.  - HugoPressThe Galena Biopharma, Inc.  Given Consensus Recommendation of Hold by ... - DailyQuint'
p3
aS'Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against ... Yahoo Finance - Mar 17, 2017 NEW YORK, NY / ACCESSWIRE / March 17, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Galena Biopharma, Inc.  investors who purchased Galena stock between August 11, 2014 and January 31, 2017, inclusive (the&nbsp;...'
p4
aS'GALE STOCK LOSS: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors of ... GlobeNewswire  - Mar 17, 2017 NEW YORK, March 17, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc. securities  from August 11, 2014 through January 31, 2017, both dates inclusive (the&nbsp;...'
p5
aS'IMPORTANT GALENA BIOPHARMA, INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 24, 2017 NEW YORK, Feb. 24, 2017  -- Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a federal securities class action has been filed in the United States District Court for the District of New Jersey against Galena Biopharma, Inc.'
p6
aS"Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim ... GlobeNewswire  - Feb 21, 2017 SAN RAMON, Calif., Feb. 21, 2017  -- Galena Biopharma, Inc. , a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced that the Company's&nbsp;...Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc. - Yahoo FinanceGalena Biopharma Inc.  Plunges 9.19% on February 22 - Equities.com"
p7
aS'SHAREHOLDR NOTICE: Khang &amp; Khang LLP Announces Securities Class Action Lawsuit ... Yahoo Finance - Mar 20, 2017 IRVINE, CA / ACCESSWIRE / March 20, 2017 / Khang &amp; Khang LLP  announces the filing of a class action lawsuit against Galena Biopharma Inc.   concerning possible violations of federal securities laws.'
p8
aS'Galena Biopharma Inc  Pulls in Gains For the Week Business Review - 10 hours ago Pushing higher over the last five sessions are shares of Galena Biopharma Inc . The stock has risen 7.83% over that span, yielding profits for savvy traders.'
p9
aS'GALENA BIOPHARMA, INC.  Files An 8-K Departure of Directors or ... Market Exclusive - Mar 13, 2017 Galena Biopharma, Inc. is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs.'
p10
a.